The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
NCCN Guidelines Insights: Bone Cancer, Version 2.2017
Open accessAbstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ® ) are a statement of consensus of the authors regarding their views of currently accepted approaches to treatment.The NCCN Guidelines ® Insights highlight important changes to the NCCN Guidelines ® recommendations from previous versions.Colored markings in the algorithm show changes and the discussion aims to further the understanding of these changes by summarizing salient portions of the NCCN Guideline Panel discussion, including the literature reviewed.These NCCN Guidelines Insights do not represent the full NCCN Guidelines; further, the National Comprehensive Cancer Network ® (NCCN ® ) makes no representation or warranties of any kind regarding the content, use, or application of the NCCN Guidelines and NCCN Guidelines Insights and disclaims any responsibility for their applications or use in any way.The full and most current version of these NCCN Guidelines are available at NCCN.org.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grier, H. E., Krailo, M. D., Tarbell, N. J., Link, M. P., Fryer, C. J. H., Pritchard, D. J., Gebhardt, M. C., Dickman, P. S., Perlman, E. J., Meyers, P. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020890 · Cited by 1,328
Delattre, O., Zucman, J., Melot, T., Garau, X. S., Zucker, J.-M., Lenoir, G. M., Ambros, P. F., Sheer, D., Turc-Carel, C., Triche, T. J., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408043310503 · Cited by 1,107
Cotterill, S. J., Ahrens, S., Paulussen, M., Jürgens, H. F., Voûte, P. A., Gadner, H., & Craft, A. W. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3108 · Cited by 1,040
Kager, L., Zoubek, A., Pötschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.132 · Cited by 934
Womer, R. B., West, D. C., Krailo, M. D., Dickman, P. S., Pawel, B. R., Grier, H. E., Marcus, K., Sailer, S., Healey, J. H., Dormans, J. P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5703 · Cited by 757
Nesbit, M. E., Gehan, E. A., Burgert, E. O., Vietti, T. J., Cangir, A., Tefft, M., Evans, R., Thomas, P., Askin, F. B., & Kissane, J. M. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.10.1664 · Cited by 570
Ewing's Sarcoma Family of Tumors: Current Management
Bernstein, M., Kovar, H., Paulussen, M., Randall, R. L., Schuck, A., Teot, L. A., & Juergensg, H. (2006) · The Oncologist · doi:10.1634/theoncologist.11-5-503 · Cited by 520
Self-citationLocalized Ewing Tumor of Bone: Final Results of the Cooperative Ewing’s Sarcoma Study CESS 86
Paulussen, M., Ahrens, S., Dunst, J., Winkelmann, W., Exner, G. U., Kotz, R., Amann, G., Dockhorn-Dworniczak, B., Harms, D., Müller-Weihrich, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1818 · Cited by 445
Burgert, E. O., Nesbit, M. E., Garnsey, L. A., Gehan, E. A., Herrmann, J., Vietti, T. J., Cangir, A., Tefft, M., Evans, R., & Thomas, P. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1514 · Cited by 380
Molecular Biology of the Ewing’s Sarcoma/Primitive Neuroectodermal Tumor Family
de Alava, E., & Gerald, W. L. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.204 · Cited by 360
Schuck, A., Ahrens, S., Paulussen, M., Kuhlen, M., Könemann, S., Rübe, C., Winkelmann, W., Kotz, R., Dunst, J., Willich, N., et al. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03797-5 · Cited by 348
Granowetter, L., Womer, R., Devidas, M., Krailo, M., Wang, C., Bernstein, M., Marina, N., Leavey, P., Gebhardt, M., Healey, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1478 · Cited by 330
Miser, J. S., Kinsella, T. J., Triche, T. J., Tsokos, M., Jarosinski, P., Forquer, R., Wesley, R., & Magrath, I. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.8.1191 · Cited by 317
Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studies
Paulussen, M., Ahrens, S., Burdach, S., Craft, A., Dockhorn-Dworniczak, B., Dunst, J., Fröhlich, B., Winkelmann, W., Zoubek, A., & Jürgens, H. (1998) · Annals of Oncology · doi:10.1023/a:1008208511815 · Cited by 317
Saylors, R. L., Stine, K. C., Sullivan, J., Kepner, J. L., Wall, D. A., Bernstein, M. L., Harris, M. B., Hayashi, R., & Vietti for the Pediatric Oncology Group, T. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3463 · Cited by 315
Risk of recurrence and survival after relapse in patients with Ewing sarcoma
Stahl, M., Ranft, A., Paulussen, M., Bölling, T., Vieth, V., Bielack, S., Görtitz, I., Braun‐Munzinger, G., Hardes, J., Jürgens, H., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23040 · Cited by 315
Juergens, C., Weston, C., Lewis, I., Whelan, J., Paulussen, M., Oberlin, O., Michon, J., Zoubek, A., Juergens, H., & Craft, A. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20820 · Cited by 282
Paulussen, M., Craft, A. W., Lewis, I., Hackshaw, A., Douglas, C., Dunst, J., Schuck, A., Winkelmann, W., Köhler, G., Poremba, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5720 · Cited by 263
Furman, W. L., Stewart, C. F., Poquette, C. A., Pratt, C. B., Santana, V. M., Zamboni, W. C., Bowman, L. C., Ma, M. K., Hoffer, F. A., Meyer, W. H., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1815 · Cited by 235
Self-citationG�bel, V., J�rgens, H., Etsp�ler, G., Kemperdick, H., Jungblut, R. M., Stienen, U., & G�bel, U. (1987) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00391442 · Cited by 233
Cangir, A., Vietti, T. J., Gehan, E. A., Burgert, E. O., Thomas, P., Tefft, M., Nesbit, M. E., Kissane, J., & Pritchard, D. (1990) · Cancer · doi:10.1002/1097-0142(19900901)66:5<887::aid-cncr2820660513>3.0.co;2-r · Cited by 217
Leavey, P. J., Mascarenhas, L., Marina, N., Chen, Z., Krailo, M., Miser, J., Brown, K., Tarbell, N., Bernstein, M. L., Granowetter, L., et al. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21618 · Cited by 204
Miser, J. S., Krailo, M. D., Tarbell, N. J., Link, M. P., Fryer, C. J. H., Pritchard, D. J., Gebhardt, M. C., Dickman, P. S., Perlman, E. J., Meyers, P. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.041 · Cited by 203
Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma
Wagner, L. M., McAllister, N., Goldsby, R. E., Rausen, A. R., McNall‐Knapp, R. Y., McCarville, M. B., & Albritton, K. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.20697 · Cited by 197
Irinotecan and temozolomide for Ewing sarcoma: The Memorial Sloan‐Kettering experience
Casey, D. A., Wexler, L. H., Merchant, M. S., Chou, A. J., Merola, P. R., Price, A. P., & Meyers, P. A. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22206 · Cited by 190
DuBois, S. G., Krailo, M. D., Gebhardt, M. C., Donaldson, S. S., Marcus, K. J., Dormans, J., Shamberger, R. C., Sailer, S., Nicholas, R. W., Healey, J. H., et al. (2015) · Cancer · doi:10.1002/cncr.29065 · Cited by 189
Self-citationKolb, E. A., Kushner, B. H., Gorlick, R., Laverdiere, C., Healey, J. H., LaQuaglia, M. P., Huvos, A. G., Qin, J., Vu, H. T., Wexler, L., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.033 · Cited by 180
Le Deley, M.-C., Paulussen, M., Lewis, I., Brennan, B., Ranft, A., Whelan, J., Le Teuff, G., Michon, J., Ladenstein, R., Marec-Bérard, P., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.4833 · Cited by 179
Analysis of prognostic factors in Ewing sarcoma using a population‐based cancer registry
Lee, J., Hoang, B. H., Ziogas, A., & Zell, J. A. (2010) · Cancer · doi:10.1002/cncr.24937 · Cited by 170
Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors
Hunold, A., Weddeling, N., Paulussen, M., Ranft, A., Liebscher, C., & Jürgens, H. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20719 · Cited by 168
Haeusler, J., Ranft, A., Boelling, T., Gosheger, G., Braun‐Munzinger, G., Vieth, V., Burdach, S., van den Berg, H., Juergens, H., & Dirksen, U. (2010) · Cancer · doi:10.1002/cncr.24740 · Cited by 166
Bacci, G., Forni, C., Longhi, A., Ferrari, S., Donati, D., De Paolis, M., Barbieri, E., Pignotti, E., Rosito, P., & Versari, M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.08.022 · Cited by 164
Navid, F., Willert, J. R., McCarville, M. B., Furman, W. L., Watkins, A., Roberts, W., & Daw, N. C. (2008) · Cancer · doi:10.1002/cncr.23586 · Cited by 153
Yock, T. I., Krailo, M., Fryer, C. J., Donaldson, S. S., Miser, J. S., Chen, Z., Bernstein, M. L., Laurie, F., Gebhardt, M. C., Grier, H. E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9188 · Cited by 152
Ewing’s Sarcoma: Standard and Experimental Treatment Options
Subbiah, V., Anderson, P. M., Lazar, A. J., Burdett, E., Raymond, K. A., & Ludwig, J. A. (2009) · Current Treatment Options in Oncology · doi:10.1007/s11864-009-0104-6 · Cited by 150
The Multidisciplinary Management of Osteosarcoma
Federman, N. C., Bernthal, N. M., Eilber, F. C., & Tap, W. D. (2009) · Current Treatment Options in Oncology · doi:10.1007/s11864-009-0087-3 · Cited by 149
Wagner, L. M., Crews, K. R., Iacono, L. C., Houghton, P. J., Fuller, C. E., McCarville, M. B., Goldsby, R. E., Albritton, K. H., Stewart, C. F., & Santana, V. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0175 · Cited by 139
Self-citationBernstein, M. L., Devidas, M., Lafreniere, D., Souid, A.-K., Meyers, P. A., Gebhardt, M. C., Stine, K. C., Nicholas, R. W., Perlman, E. J., Dubowy, R. L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.1717 · Cited by 135
Winkle, P. J. V., Angiolillo, A. L., Krailo, M., Cheung, Y.-K. K., Anderson, B. D., Davenport, V. D., Reaman, G. H., & Cairo, M. S. (2004) · Pediatric Blood & Cancer · doi:10.1002/pbc.20227 · Cited by 125
A phase I study of irinotecan in pediatric patients: a pediatric oncology group study.
Blaney, S. M., Berg, S. L., Pratt, C. B., Weitman, S., Sullivan, J., Luchtman‐Jones, L., & Bernstein, M. L. (2001) · PubMed · Cited by 117
Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma
Raciborska, A., Bilska, K., Drabko, K. A., Chaber, R., Pogorzała, M., Wyrobek, E., Połczyńska, K., Rogowska, E., Galindo, C. R., & Wozniak, W. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24621 · Cited by 98
Oberlin, O., Habrand, J., Zucker, J. M., Brunat-Mentigny, M., Terrier-Lacombe, M.-J., Dubousset, J., Gentet, J. C., Schmitt, C., Ponvert, D., & Carrié, C. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.9.1407 · Cited by 98
Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors
Kushner, B. H., Kramer, K., Meyers, P. A., Wollner, N., & Cheung, N. V. (2000) · Medical and Pediatric Oncology · Cited by 68
Schuck, A., Ahrens, S., von Schorlemer, I., Kuhlen, M., Paulussen, M., Hunold, A., Gosheger, G., Winkelmann, W., Dunst, J., Willich, N. A., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.05.036 · Cited by 67
Post‐relapse survival in patients with Ewing sarcoma
Ferrari, S., Luksch, R., Hall, K. S., Fagioli, F., Prete, A., Tamburini, A., Tienghi, A., Girolamo, S. D., Paioli, A., Abate, M. E., et al. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25388 · Cited by 64
Indelicato, D. J., Keole, S. R., Shahlaee, A. H., Shi, W., Morris, C. G., & Marcus, R. B. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.02.023 · Cited by 62
Self-citationThe value of high‐dose chemotherapy in patients with first relapsed Ewing sarcoma
Rasper, M., Jabar, S., Ranft, A., Jürgens, H., Amler, S., & Dirksen, U. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25042 · Cited by 61
Pan, H. Y., Morani, A. C., Wang, W., Hess, K. R., Paulino, A. C., Ludwig, J. A., Lin, P. P., Daw, N. C., & Mahajan, A. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.01.022 · Cited by 36
Molecular abnormalities in Ewing’s sarcoma
Burchill, S. A. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.10.1675 · Cited by 34
McGregor, L. M., Stewart, C. F., Crews, K. R., Tagen, M., Wozniak, A. W., Wu, J., McCarville, M. B., Navid, F., Santana, V. M., Houghton, P. J., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23075 · Cited by 31
Self-citationvan Maldegem, A. M., Benson, C., Rutkowski, P. L., Blay, J., van den Berg, H., Placzke, J., Rasper, M., Judson, I. R., Juergens, H., Dirksen, U., et al. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25230 · Cited by 26
Cited by
OncoKB: A Precision Oncology Knowledge Base
Chakravarty, D., Gao, J., Phillips, S., Kundra, R., Zhang, H., Wang, J., Rudolph, J. E., Yaeger, R., Soumerai, T., Nissan, M. H., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00011 · Cited by 2,589
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Duffaud, F., Mir, O., Boudou-Rouquette, P., Piperno-Neumann, S., Penel, N., Bompas, E., Delcambre, C., Kalbacher, E., Italiano, A., Collard, O., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30742-3 · Cited by 331
Personalized chordoma organoids for drug discovery studies
Al Shihabi, A., Davarifar, A., Nguyen, H. T. L., Tavanaie, N., Nelson, S. D., Yanagawa, J., Federman, N., Bernthal, N., Hornicek, F., & Soragni, A. (2022) · Science Advances · doi:10.1126/sciadv.abl3674 · Cited by 75
Self-citation
Metadata
- Authors
- Biermann, J. S., Chow, W., Reed, D. R., Lucas, D., Adkins, D. R., Agulnik, M., Benjamin, R. S., Brigman, B., Budd, G. T., Curry, W. T., Didwania, A., Fabbri, N., Hornicek, F. J., Kuechle, J. B., Lindskog, D., Mayerson, J., McGarry, S. V., Million, L., Morris, C. D., Movva, S., O'Donnell, R. J., Randall, R. L., Rose, P., Santana, V. M., Satcher, R. L., Schwartz, H., Siegel, H. J., Thornton, K., Villalobos, V., Bergman, M. A., & Scavone, J. L.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2017-02
- Volume
- 15
- Issue
- 2
- Pages
- 155-167
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2594071156
- Cited by
- 294
- References
- 51
- FWCI
- 21.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.